• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » GENEWIZ acquires Beckman Coulter’s genomic services business

GENEWIZ acquires Beckman Coulter’s genomic services business

December 22, 2015
CenterWatch Staff

GENEWIZ, a leading global genomics service provider, has signed a definitive agreement to acquire the genomic services business of Danvers, Mass.-based Beckman Coulter.

Beckman Coulter delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide.

“The genomic services business of Beckman Coulter is an ideal fit with GENEWIZ’s global strategy and expansion plans,” said Dr. Steve Sun, chairman and CEO of Suzhou, China-based GENEWIZ. “Our two companies share a common mission and vision: to offer scientists around the world consistently reliable genomics service solutions that will advance innovations and scientific discoveries.”

The synergies of this acquisition will support GENEWIZ’s global expansion strategy by leveraging Beckman Coulter’s 25-plus years of genomics expertise and capabilities. The U.S. company’s comprehensive Sanger Sequencing, Next Generation Sequencing, Bioinformatics, and CLIA/Clinical Services will complement GENEWIZ’s existing genomics services. With an international presence in the U.S. and a Pan-European presence centered in the U.K., Beckman Coulter presents an immediate opportunity to strengthen GENEWIZ’s global access and value to customers through a stronger network of global labs and office locations in the U.S., U.K., China and Japan.

“Their proven leadership and experienced team of industry experts have built an efficient workflow that allows for the delivery of quality and timely results to its customers,” said Sun. “The integration of these two businesses will allow for an increased level of service and value to customers worldwide. We look forward to working with the talented Beckman Coulter team to best serve our customers, and be an instrumental part of the future growth of GENEWIZ.”

The two companies will collaboratively align to ensure there is a seamless transition for both organizations and its customer base. The agreement has been approved by the boards of directors of both companies and is effective immediately.

In addition to its locations in China, GENEWIZ has several in the U.S., as well as others in London and Tokyo.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing